About OrthoLogic Research & Development Investors Fact Sheet Stock Information SEC Filings Financial Reports Corporate Governance Corporate Presentation Request Information Press Releases Calendar of Events Quarterly Results Earnings Estimates Analysts Fundamentals Email Alerts
Jul 9, 2008 - OrthoLogic Announces Initiation of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
Jul 1, 2008 - OrthoLogic Joins Russell Microcap Index
May 8, 2008 - OrthoLogic Announces Positive Safety Data for Initial AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
May 7, 2008 - OrthoLogic Announces First Quarter 2008 Financial Results and Conference Call
- Past Press Releases
